Ascendis CEO Mark Sardi. Picture: SUPPLIED
Loading ...

High debt levels, restructuring costs, rising finance charges and the Covid-19 pandemic have all weighed on Ascendis Health’s annual performance as its loss per share from total operations widened to 226.5c.

But the company is now charting a course with slimmed down operations after a restructuring plan left it with just three SA businesses.

Business Day TV spoke to Ascendis Health CEO Mark Sardi​ about the company’s performance.

Loading ...
Loading ...
Loading ...
View Comments